The importance of patient preferences for comorbidities in cost- effectiveness analyses

Journal of Health Economics

Volumn 16, Issue 1, 1997, Pages 113-119

  Harris, Ryan A ^a,b,d   Nease Jr , Robert F ^c  

^a STANFORD UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NONE   (United States)

Author keywords

Comorbidities; Cost effectiveness; Cost utility ratios

Indexed keywords

ARTICLE; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH CARE UTILIZATION; PATIENT CARE; TASTE PREFERENCE;

EID: 0030920580     PISSN: 01676296     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-6296(96)00510-3     Document Type: Article

References (17)

1. Bass, E.B., H.A. Pitt and K.D. Lillemoe, Cost-effectiveness of laparoscopic cholecystectomy versus open cholecystectomy, Am. J. Surg., 165 (1993) 466-471.
2. Cantor, S.B., R.D. Clover and R.F. Thompson, A decision-analytic approach to postexposure rabies prophylaxis, Am. J. Publ. Health, 84 (1994) 1144-1148.
3. Campeau, L., Grading of angina pectoris (letter), Circulation, 54 (1976) 522-523.
4. Detsky, A.S., J.R. McLaughlin, H.B. Abrams, J.S. Whittaker, J. Whitwell, K. L'Abbe and K.N. Jeejeebhoy, A cost-utility analysis of the home parenteral nutrition program at Toronto General Hospital: 1970-1982, J. Parent. Enteral Nutr., 10 (1986) 49-57.
5. Froberg, D.G. and R.L. Kane, Methodology for measuring health-state preferences - II: scaling methods, J. Clin. Epidemiol., 42 (1989) 459-471.
6. Fryback, D.G., E.J. Dasbach, R. Klein, B.E. Klein, N. Dorn, K. Peterson and P.A. Martin, The Beaver Dam health outcomes study: initial catalog of health-state quality factors, Med. Decision Making, 13 (1993) 89-102.
7. Hillner, B.E., T.J. Smith and C.E. Desch, Efficacy and cost-effectiveness of autologous bone marrow transplantation in metastatic breast cancer. Estimates using decision analysis while awaiting clinical trial results, J. Am. Med. Assoc., 267 (1992) 2055-2061.
8. Nease Jr, R.F., T. Kneeland, G.T. O'Connor, W. Sumner, C. Lumpkins, L. Shaw, D. Pryor and H.C. Sox, Variation in patient utilities for outcomes of the management of chronic stable angina. Implications for clinical practice guidelines, J. Am. Med. Assoc., 273 (1995) 1185-1190.
9. O'Connor, G. and R.F. Nease Jr, The descriptive epidemiology of health-state values and utilities, Med. Decision Making, 13 (1993) 87-88.
10. Pliskin, J.S., D.S. Shephard and M.C. Weinstein, Utility functions for life years and health status, Ops Res., 28 (1980) 206-224.
11. Simoons, M.L., J. Vos and L.L. Martens, Cost-utility analysis of thrombolytic therapy, Eur. Heart J., 12 (1991) 694-699.
12. Sox, H., M. Blatt, M. Higgins and K. Marton, Medical Decision Making, Butterworths, Boston, MA.
13. Torrance, G.W., Utility approach to measuring health-related quality of life, J. Chronic Dis., 40 (1987) 593-603.
14. Torrance, G.W. and D. Feeny, Utilities and quality-adjusted life years, Int. J. Technol. Assess. Health Care, 5 (1989) 559-575.
15. Tousignant, P., M.G. Cosio, R.D. Levy and P.A. Groome, Quality adjusted life years added by treatment of obstructive sleep apnea, Sleep, 17 (1994), 52-60.
16. Weinstein, M.C., Principles of cost-effective resource allocation in health care organizations, Int. J. Technol. Assess. Health Care, 6 (1990) 93-103.
17. Weinstein, M.C. and H.V. Fineberg, Clinical Decision Analysis, Saunders, Philadelphia, PA.